Search Results 1651-1660 of 17253 for mchc
ROCHESTER, Minn. — Mayo Clinic researchers have discovered a key reason some cancer patients relapse after receiving chimeric antigen receptor T-cell therapy, ...
Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.
Research · Mayo Clinic research yields breakthrough in mobile determination of QT prolongation featured image · Science Saturday: Mayo Clinic scientists identify ...
Type: Fellowship · Duration: 2 years · School: Graduate Medical Education · Specialty: Surgery Specialties, Obstetrics & Gynecology ...
About this study. The purpose of this study is to determine the incidence of rPSC in LT recipients treated with fenofibrate, compared with an untreated ...
The purpose of this study is to evaluate the efficacy and safety of a single dose of NTLA-2001 compared to placebo in participants with ATTR-CM. Participation ...
ROCHESTER, Minn. — Mayo Clinic Comprehensive Cancer Center researchers will present their latest oncology findings at the 2025 American Society of Clinical ...
ST. PAUL, Minn. – Minnesota Oncology and Mayo Clinic announced today that Minnesota Oncology is the newest member of the Mayo Clinic Care Network.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Chimeric antigen receptor-T cell therapy (CAR-T cell therapy) could provide a revolutionary approach to organ transplantation for patients who are hard to match ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.